US$ 21.71
glp 1 weight loss after stopping The part of GLP-1 nobody talks about๐ Think of your metabolism like a battery. As appetite drops and the weight comes off, your body starts conserving energy because you're consuming Patients with Higher Initial BMIs
Description
We and others have shown that GLP-1 drugs reduce risks of many substance use and addiction disorders.

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH
A two-step MR analysis was further employed to explore potential mediating factors in the T2D-SA relationship

- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake
